Tag: Competition

Displaying 1381 - 1400 of 2073 results.

Pages

Federal Trade Commission Chairman Jon Leibowitz announced today that David P. Wales, Acting Director of the Bureau of Competition for the past nine months, will leave the FTC in May. “Dave has done a terrific job in leading the Bureau of Competition during an active period of antitrust enforcement...
Testifying today on behalf of the Federal Trade Commission before the U.S. House Subcommittee on Commerce, Trade, and Consumer Protection of the Committee on Energy and Commerce, FTC Commissioner J. Thomas Rosch said that anticompetitive patent settlements in the U.S. pharmaceutical industry “...
Drug maker Bristol-Myers Squibb Company (BMS) will pay $2.1 million – the largest fine allowed by law – for failing to inform the Federal Trade Commission of agreements reached with Apotex, Inc., regarding potential generic competition to its blockbuster drug Plavix. BMS’s conduct violated a 2003...
Drug maker Bristol-Myers Squibb Company (BMS) agreed to pay $2.1 million – the largest fine allowed by law – for failing to inform the FTC of agreements reached with Apotex, Inc., regarding potential generic competition to its blockbuster drug Plavix. BMS’s conduct violated a 2003...
According to the staff of the Federal Trade Commission, legislation pending before the Minnesota legislature that seeks to exempt certain activities by Minnesota health care cooperatives from federal and state antitrust law likely would raise health care costs and reduce insurance coverage for...
The Federal Trade Commission today announced the fourth in a series of public hearings exploring the evolving market for intellectual property. These hearings, to be held April 17, 2009, in Washington, DC, will explore how corporations, inventors, and patent intermediaries value and monetize...
– Following a public comment period, the Commission has approved a final consent order in the matter of Getinge AB and Datascope Corp. The vote approving the final order was 3-0, with Commissioner Pamela Jones Harbour recused. (FTC File No. 091-0000; the staff contact is David L. Inglefield,...
The United States District Court for the District of Columbia announced its decision today granting the Federal Trade Commission’s request for a preliminary injunction enjoining CCC Information Services Inc.’s merger with Mitchell International Inc.
The National Association of Music Merchants (NAMM), a trade association with more than 9,000 members nationwide, settled charges that it violated federal law by enabling and encouraging the exchange of competitively sensitive price information among its members. The FTC alleged that...
– The FTC has approved the appointment of Quantic Regulatory Services, LLC as the interim monitor in the matter concerning Getinge AB’s acquisition of Datascope Corporation, and also has approved the related interim monitor agreement. On January 29, 2009, the Commission voted to accept a consent...
The Commission challenged Lubrizol Corporation’s consummated 2007 acquisition of the oxidate assets of The Lockhart Company which had the effect of substantially lessening competition in the already highly concentrated U.S. market for chemical rust inhibitors. These inhibitors are...
The Federal Trade Commission has intervened in Lubrizol Corporation’s 2007 acquisition of the oxidate assets of rival firm The Lockhart Company, which the agency contends violated the antitrust laws and lessened competition in the U.S. market for these chemical rust inhibitors. Under a consent...
The Federal Trade Commission today announced the third in a series of public hearings exploring the evolving market for intellectual property (IP). These hearings, to be held March 18 and 19, 2009, in Washington, DC, will examine the operation of markets for IP and technology and the impact of...
Statement by David P. Wales, Acting Director of the FTC’s Bureau of Competition, on the Commission’s Order today extending by thirty days the time the lawsuit against Whole Foods Market, Inc. will be withdrawn from Part 3 adjudication: “We look forward to continuing our discussions with Whole...
Commission Approves Final Consent Order in Matter of AllCare IPA – Following a public comment period, the Commission has approved a final consent order in the matter of AllCare IPA. The vote approving the final order was 4-0. (FTC File No. 061-0258; the staff contact is John P. Wiegand, FTC...
The Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay’s branded testosterone-...
The Commission challenged Getinge AB’s proposed $865 million acquisition of rival Datascope Corporation as anticompetitive in the market for endoscopic vessel harvesting devices (EVHs). EVHs are used during coronary artery bypass graft surgery where a vein is removed from a patients...
Getinge AB has settled Federal Trade Commission charges that its proposed $865 million acquisition of rival Datascope Corporation would be anticompetitive and would violate federal antitrust laws. Under the settlement with the Commission, Datascope is required to divest its endoscopic vessel...
The Commission challenged Dow Chemical’s $18.8 billion proposed acquisition of Rohm & Haas Company as anticompetitive in the markets for various acrylics and other industrial chemicals used to make coated paper products, paints, and adhesives. According to the Commission’s...
Dow Chemical Company has settled Federal Trade Commission charges that its proposed $18.8 billion acquisition of rival chemical manufacturer Rohm & Haas Company would be anticompetitive and would violate federal law. Under the proposed consent order allowing the transaction to proceed, Dow...

Pages